Related Experiment Video

Updated: Jun 26, 2026

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles
09:15

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles

Published on: November 10, 2017

Atherosclerotic plaque reduction: blood pressure, dyslipidemia, atherothrombosis

Satish Arora1, Stephen J Nicholls

  • 1Department of Cardiology, Rikshospitalet-Radiumhospitalet Medical Center, Oslo, Norway.

Drugs of Today (Barcelona, Spain : 1998)
|January 13, 2009
PubMed

Insights

Intravascular ultrasound (IVUS) quantifies atherosclerotic plaque burden, aiding the development of new therapies for coronary heart disease (CHD). Serial IVUS confirms that intensive risk factor modification benefits patients with established CHD.

Area of Science:

  • Cardiovascular Medicine
  • Medical Imaging

Background:

  • Coronary heart disease (CHD) is a major global health concern.
  • Modifying cardiovascular risk factors is crucial for managing CHD.
  • Novel therapeutic strategies and advanced imaging are essential for CHD research.

Purpose of the Study:

  • To evaluate the role of biomarkers and imaging in assessing novel CHD therapies.
  • To explore the utility of intravascular ultrasound (IVUS) in quantifying atherosclerotic plaque.
  • To investigate the impact of risk factor modification on CHD progression.

Main Methods:

  • Utilized intravascular ultrasound (IVUS) for sensitive imaging of artery walls.
  • Quantified atheroma burden and monitored serial changes in atherosclerotic plaque.
  • Assessed the efficacy of therapeutic strategies and risk factor modification.

Main Results:

  • IVUS enables precise quantification of atheroma burden.
  • IVUS provides insights into plaque pathophysiology and therapeutic impacts.
  • Serial IVUS demonstrated that intensive risk factor modification benefits CHD patients.

Conclusions:

  • IVUS is a key tool for evaluating antiatherosclerotic therapies.
  • Intensive management of risk factors like lipids and blood pressure is beneficial for established CHD.
  • Technological advancements in imaging enhance understanding and treatment of CHD.

Related Concept Videos

Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Atherosclerosis I: Introduction01:30

Atherosclerosis I: Introduction

Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
Atherosclerosis IV: Nursing Management01:23

Atherosclerosis IV: Nursing Management

Nursing management for a patient with arteriosclerosis involves a comprehensive approach focusing on lifestyle modification, disease monitoring, education, and symptomatic care. Here is an overview of effective nursing strategies:Assessment and Monitoring: Initial and ongoing assessments are crucial. Nurses must document the patient's medical history, including any hypertension, diabetes, hyperlipidemia, and other cardiovascular diseases. Assessments also cover family history and lifestyle...
Peripheral Artery Disease III: Interprofessional Care01:27

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
Lipid-Lowering Drugs: Statins and Miscellaneous Agents01:20

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...